drugset / Trial / NCT04350450
Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk for severe COVID19 illness.
Timeline
- Start
- 2020-04
- Primary completion
- 2020-08
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 400 mg | — |